Skip to main content
glpverdict
Subscribe⊙Sign in
🔍12+ medical reviewers in network🏆FDA & peer-reviewed sources📈Updated weekly🩺Medically reviewed content

Newsletter

Weekly GLP-1 updates, no filler

Shortages, savings, new approvals, and reviewer-vetted guidance. 5 min/week.

Free Week-1 Survival Kit PDF on signup· 5,400+ readers · weekly · unsubscribe anytime

glpverdict

Evidence-based GLP-1 reviews. Medically reviewed, affiliate-funded, editorially independent.

Language

EnglishEspañol

Compare providers

  • Best overall
  • Cheapest
  • Best rated
  • Accepts insurance
  • Most medications
  • Side-by-side

Medications

  • Wegovy
  • Ozempic
  • Zepbound
  • Mounjaro
  • Saxenda
  • Rybelsus
  • All medications

Tools

  • Match me to a provider
  • Eligibility checker
  • Weight-loss projection
  • PAP eligibility
  • Symptom triage
  • Insurance coverage
  • All tools

Coverage & savings

  • Insurance appeals
  • GLP-1 cost by state
  • Cost trends
  • Compounded vs brand
  • Switching guides
  • Shortage tracker
  • Drug pipeline

Research & editorial

  • Primary-data research
  • GLP-1 Diaries
  • News + recalls
  • Lawsuit + MDL tracker
  • Q&A library
  • Glossary
  • Editorial board
  • Editorial standards
  • Press kit

GLP-1 by audience

  • Sleep
  • Fitness
  • Mental health
  • Pediatric
  • Veterans
  • Medicare
  • Seniors
  • Men
  • Postmenopausal
  • Trans + gender-diverse
  • Post-bariatric

For informational purposes only. Not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication. © 2026 Glpverdict.

  • Medically reviewed
  • FDA + peer-reviewed
  • Updated weekly
  • Independent ranking
HomeTop picksMedsQuizSaved
HomeToolsWeight Loss Estimator

Free tool

GLP-1 Weight Loss Estimator

Project your expected weight loss on Wegovy, Zepbound, Ozempic, or Mounjaro using FDA pivotal-trial data.

TimepointMean lossEnd weightRange
Week 1613.0 lbs (5.9%)207.0 lbs200.5 lbs — 213.5 lbs
Week 2418.9 lbs (8.6%)201.1 lbs191.6 lbs — 210.5 lbs
Week 52 (1 year)29.7 lbs (13.5%)190.3 lbs175.4 lbs — 205.2 lbs
Week 68 (~16 months)32.8 lbs (14.9%)187.2 lbs170.8 lbs — 203.6 lbs

Estimates are based on STEP-1 (NEJM 2021) mean values. Individual results vary substantially with diet, exercise, comorbidities, adherence, and biological factors. Discontinuation typically results in weight regain. Not medical advice.

Data sources

  • Wegovy: Wilding et al., NEJM 2021 (STEP-1) — 14.9% mean loss at 68 weeks
  • Zepbound: Jastreboff et al., NEJM 2022 (SURMOUNT-1) — 20.9% at 72 weeks
  • Ozempic / Mounjaro off-label: clinical-practice data, individual results vary